102 EUR
0
0%
Last update Dec 15, 8:13 AM CET
Main market
Day range
102
102
Previous close
102
Open
102
Access this stock data via API
Subscribe
Cosmo Pharmaceuticals N.V.
102.00
0
0%

Financials

Income statement

Fiscal date 2024 2023 2022
Total reported revenue 266.8M 92.8M 102.1M
Cost of revenue 19.9M 19.1M 18.8M
Gross profit 246.9M 73.7M 83.3M
Operating expense
Research & development 373K 3.2M
Selling general and admin 7.4M 5.3M 3.6M
Other operating expenses 34.6M 25.6M 14.0M
Operating income 154.9M 6.2M 28.1M
Non operating interest income
Income 1.7M 4.1M 2.9M
Expense 53K 8.5M 9.2M
Other income expense
Pretax income 153.4M -6.5M 24.5M
Tax provision 20.2M 4.2M 7.0M
Net income 133.2M -10.7M 17.5M
Basic EPS 8.1 -0.7 1.0
Diluted EPS 8.1 -0.7 1.0
Basic average shares 16.4M 16.1M 16.4M
Diluted average shares 16.4M 16.1M 16.4M
EBITDA 169.8M 25.0M 47.5M
Net income from continuing op. 153.4M -7.0M 24.5M
Minority interests 45K -80K -280K
Preferred stock dividends 0 0 0
Access /income_statement data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 6 hours 5 minutes

13:54
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).